Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Brain : a Journal of Neurology|October 9, 2009
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohortCaroline H Williams-Gray, Jonathan R Evans, An Goris, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 22, 2016
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)Caroline H Williams-Gray, Ruwani Wijeyekoon, Alison J Yarnall, et al.
Neurology|February 19, 2016
Development and external validation of a prognostic model in newly diagnosed Parkinson diseaseDaan C Velseboer, Rob M A de Bie, Luuk Wieske, et al.
Brain, Behavior, and Immunity|February 2, 2020
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's diseaseRuwani S Wijeyekoon, Deborah Kronenberg-Versteeg, Kirsten M Scott, et al.
Neurology|May 7, 2013
Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson diseaseGavin Hudson, Mike Nalls, Jonathan R Evans, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 22, 2011
Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndromeSophie E Winder-Rhodes, Pablo Garcia-Reitböck, Maria Ban, et al.
Neurology|December 24, 2013
Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD studyAlison J Yarnall, David P Breen, Gordon W Duncan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2012
Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's diseaseLaura L Kilarski, Justin P Pearson, Victoria Newsway, et al.
Neurology. Genetics|August 13, 2019
Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohortsHirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2019
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohortsHirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Pageof 3